The company’s main In recent years, as the problem of population aging has become increasingly serious, the incidence of chronic diseases has increas year by year, and mical and health investment has increas. Against this background, the global mical device market has expand rapidly, and the scale of the global mical device market has shown an reunion email list 100000 contact leads upward trend. As one of the subsectors of the mical device industry, the scale of ultrasonic mical imaging equipment is also on the rise.
According to SignifyResearch data, from 2019 to 2024, the global ultrasound mical imaging equipment market size is expect to grow at a compound annual growth rate of 9.13%; the Chinese ultrasound mical imaging equipment market size is expect to grow at a compound annual growth rate of 11.30%.
In terms of performance, in 2021, 2022 and 2023
Chaoyan’s operating income was approximately RMB 284 million, RMB 336 million and RMB 327 million, respectively, and the corresponding potential hardware attacks net profits were approximately RMB 76 million, RMB 127 million and RMB 115 million, respectively. The company’s net profit fluctuat.
Among them, in 2023, affect by the rectification and upgrading of the mical industry, the company’s operating income in the second half of the year decreas yearonyear; combin with the impact of exchange gains and losses, the net profit attributable to shareholders after ducting nonrecurring items in 2023 decreas by 15.92% yearonyear.
As the special action for industry rectification gradually comes
To an end, it will enter the normalization stage in the future. At the same time, the bidding activities of public hospitals and the promotion of new products philippines numbers will gradually resume in the second half of 2024. In addition, with the launch of the secondgeneration products, the company expects to achieve operating income of 374 million yuan in 2024, a yearonyear increase of 14.54%, and net profit of 127 million yuan, a yearonyear increase of 9.74% The company’s main.